{
  "id": 204270,
  "name": "ASSOCIATION FOR CLINICAL ONCOLOGY",
  "slug": "association-for-clinical-oncology",
  "state": "VA",
  "description": "Professional organization for physicians and oncology professionals.",
  "totalSpending": 1420000,
  "filings": 23,
  "yearlySpending": [
    {
      "year": 2020,
      "income": 240000
    },
    {
      "year": 2021,
      "income": 240000
    },
    {
      "year": 2022,
      "income": 240000
    },
    {
      "year": 2023,
      "income": 240000
    },
    {
      "year": 2024,
      "income": 180000
    },
    {
      "year": 2025,
      "income": 280000
    }
  ],
  "firms": [
    "TIBER CREEK GROUP"
  ],
  "lobbyists": [
    "ANDREW MCKECHNIE",
    "SEAN RICHARDSON",
    "EMILY KIRLIN",
    "BRYANT HALL",
    "COREY MALMGREN"
  ],
  "issues": [
    "HCR",
    "MMM",
    "BUD",
    null
  ],
  "sampleDescriptions": [
    "Issues related to oncology care, physician reimbursement, research funding, and the cost of prescription drugs.  Issues related to HR 913, the CLINICAL Treatment Act",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs.  Issues related to HR 913/S 4742, the CLINICAL Treatment Act",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs.",
    "H.R. 1868, Medicare Sequester.",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to H.R. 5376 - Build Back Better Act.",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to H.R. 5376 - Build Back Better Act; Issues related to FDA user fee agreements, Consolidated Appropriations Act, 2022 (PL 117-103).",
    "Issues related to research funding, Consolidated Appropriations Act, 2022 (PL 117-103).",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to H.R. 5376 - Build Back Better Act; Issues related to FDA user fee agreements (H.R.7667 and S.4348), Consolidated Appropriations Act, 2022 (PL 117-103).",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to H.R. 5376 - Build Back Better Act; H.R. 7667/S. 4348 - Food and Drug Amendments of 2022, Issues related to FDA user fee agreements; Consolidated Appropriations Act, 2022 (PL 117-103); Inflation Reduction Act of 2022 (PL 117-169); The legislative vehicle for the Continuing Resolution (PL 117-180).",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Inflation Reduction Act of 2022 (PL 117-169); Consolidated Appropriations Act, 2023 (PL 117-328).",
    "Issues related to research funding, Consolidated Appropriations Act, 2023 (PL 117-328).",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages.",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues relating to H.R.10545 - American Relief Act, 2025 (PL 118-158).",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to H.Con.Res. 14.",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21).",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 5371 - Continuing Appropriations and Extensions Act, 2026",
    "Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37)."
  ],
  "years": [
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 17,
  "trajectory": "stable",
  "yearsActive": 6,
  "avgAnnualSpending": 236667,
  "peakYear": 2025,
  "lobbyistCount": 5,
  "firmCount": 1,
  "issueCount": 3,
  "industry": "healthcare"
}